Liofilchem® Moxifloxacin MXF, Antimicrobial Susceptibility Discs, 5 μg
Catalog No :
CAS Number :
Brand :
In Stock
Specifications:
Application | Antimicrobial Susceptibility and Resistance Testing (AST) |
Storage Temperature | 2-8°C |
Product Type | Antibiotic Disc |
Product Brand | Liofilchem |
Product Grade | Microbiology grade |
The Liofilchem® Moxifloxacin (MXF) 5 µg Antimicrobial Susceptibility Discs are high-precision paper discs impregnated with 5 micrograms of moxifloxacin, a fourth-generation fluoroquinolone antibiotic. These discs are used for in vitro antimicrobial susceptibility testing (AST) of bacterial isolates, following standardized disc diffusion methods such as those outlined by EUCAST and CLSI. Each disc is manufactured to ensure consistent potency, sterility, and diffusion performance, enabling accurate determination of bacterial resistance profiles in clinical, research, and pharmaceutical microbiology laboratories.
Key Features
- Standardized Antibiotic Load – Each disc contains 5 µg of Moxifloxacin, ensuring consistent zone of inhibition results
- High-Quality Paper Discs – Uniform thickness and diffusion properties for reproducible results
- Compliant with International Standards – Conforms to EUCAST and CLSI guidelines for disc diffusion AST
- Individually Packed in Blister Strips – Protects from contamination and moisture, ensuring disc integrity
- Color-coded Labels – Clear identification for ease of use in high-throughput laboratories
- Long Shelf Life – Stable under recommended refrigerated conditions, maintaining potency over time
Technical Specifications
Property | Specification |
---|---|
Antibiotic | Moxifloxacin (MXF) |
Concentration per Disc | 5 µg |
Disc Diameter | 6 mm (standard) |
Form | Sterile, impregnated paper discs |
Packaging Format | Blister packs in cartridges |
Storage Conditions | 2–8 °C (Refrigerated) |
Shelf Life | Typically 24–36 months from date of manufacture |
Compliance | EUCAST, CLSI, ISO 20776-1 |
Catalogue Reference | [Varies by distributor/region] |
Applications
- Clinical Microbiology Laboratories – Detection of susceptibility/resistance in Staphylococcus spp., Streptococcus pneumoniae, Escherichia coli, and other Gram-positive/negative pathogens
- Pharmaceutical & Research Labs – Used in R&D for evaluating novel bacterial strains or monitoring resistance trends
- Hospital Labs – Supports antibiogram development and infection control programs
Mechanism of Action (Moxifloxacin)
Moxifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. It has broad-spectrum activity, particularly effective against Gram-positive organisms, anaerobes, and atypical pathogens.
Liofilchem® Moxifloxacin 5 µg Susceptibility Discs are reliable tools for phenotypic antimicrobial resistance testing. Backed by Liofilchem’s ISO-certified production standards, these discs ensure accuracy, consistency, and compliance for laboratory professionals dedicated to combatting antimicrobial resistance.